Prime Medicine (NASDAQ: PRME)
$5.59
(0.9%)
$0.05
Price as of October 1, 2025, 4:00 p.m. ET
Prime Medicine Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Prime Medicine Company Info
Prime Medicine, Inc. is a biotechnology company, which engages in developing one-time curative genetic therapies. The company was founded by David R. Liu on September 13, 2019 and is headquartered in Cambridge, MA.
News & Analysis
Featured Article
PRME Revenue Misses by 73%
Motley Fool Markets Team | Aug 7, 2025
Featured Article
Why Prime Medicine Stock Was Climbing Higher This Week
Eric Volkman | Mar 20, 2025
Why Prime Medicine Stock Is Soaring Today
Johnny Rice | Mar 19, 2025
Why Prime Medicine Stock Soared Nearly 12% Higher on Monday
Eric Volkman | Sep 30, 2024
Changes are afoot at the company, and investors welcomed them.
2 Growth Stocks That Could Make You Richer
George Budwell | Aug 28, 2024
Discover two cutting-edge growth stocks that could revolutionize medicine and space exploration.
2 Magnificent Growth Stocks With Room to Run
George Budwell | Mar 27, 2024
These deeply undervalued growth stocks could be big winners for patient shareholders.
Better Growth Stock: Archer Aviation or Prime Medicine?
George Budwell | Dec 19, 2023
Which of these innovation-themed growth stocks is the better buy?
1 Cathie Wood Stock That Could Deliver Life-Changing Returns in 10 Years
George Budwell | Nov 30, 2023
This gene-editing company could sport a best-in-class platform.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.